1 results
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2024-516547-11-00 check the CTIS register for the current data. To assess uptake (visual and quantitative) of 89Zr-ipilimumab in tumor lesions and biodistribution at start of nivolumab/ipilimumab…